Structured evidence table for Omega-3 Cognitive Performance Meta-Analysis, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Omega-3 Cognitive Performance Meta-Analysis | Consequently, identifying modifiable risk factors to prevent or delay cognitive decline is of critical public health importance [,]. | 4 | Liao Zheng-Bin (2026) | The association between omega-3 supplementation and cognitive decline in older adults |
| Omega-3 Cognitive Performance Meta-Analysis | By elucidating these specific neurobiological pathways, we aim to provide clinical evidence that informs the debate regarding the role of omega-3 fatty acids supplementation in slowing cognitive decline. | 4 | Liao Zheng-Bin (2026) | The association between omega-3 supplementation and cognitive decline in older adults |
| Omega-3 Cognitive Performance Meta-Analysis | 29 30 31 This study employed three commonly used cognitive scales to assess longitudinal trajectories associated with omega-3 supplementation: the Mini-Mental State Examination (MMSE), the Alzheimer’s Disease Assessment Scale–Cognitive Subscale 13 (ADAS-Cog13), and the Clinical Dementia Rating–Sum of Boxes (CDR-SB). | 4 | Liao Zheng-Bin (2026) | The association between omega-3 supplementation and cognitive decline in older adults |
| Omega-3 Cognitive Performance Meta-Analysis | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 in vivo Alzheimer’s disease (AD), the leading cause of dementia, imposes a growing global public health burden []. | 4 | Liao Zheng-Bin (2026) | The association between omega-3 supplementation and cognitive decline in older adults |
Source documents